期刊文献+

组织型纤溶酶原激活物-抑制剂复合物与冠心病风险的相关性研究 被引量:10

The study on the association between tissue plasminogen activator-plasminogen activator inhibitor-1 complex and risk of coronary disease
原文传递
导出
摘要 目的探讨组织型纤溶酶原激活物-抑制剂复合物(t-PAIC)在预估冠状动脉粥样硬化性心脏病发生风险中的临床价值。方法回顾性分析。选取2017年1月至2018年3月于武汉大学人民医院心血管内科收治的冠心病患者203例,并选取同期对照组130例。对所有患者的血浆t-PAIC,全血红细胞、血红蛋白、白细胞和其他常规生化标志物的血清浓度进行定量。结果与对照组7.70(6.10~9.41)ng/ml相比,冠心病患者具有较高的t-PAIC 12.75(9.0~17.93)ng/ml水平,差异有统计学意义(Z=9.208, P〈0.001)。Logistic回归结果显示:TG、LPa、t-PAIC是冠心病发病的独立危险因素[OR值(95% CI)],[1.762(1.076~2.884); 1.002 (1.000~1.003);1.338(1.171~1.529)]。血浆t-PAIC浓度与冠心病严重程度呈正相关,冠状动脉堵塞轻微组(11.64±0.59)ng/ml、严重组(15.84±0.72)ng/ml血浆t-PAIC浓度逐步升高,且血浆t-PAIC与Gensini评分呈正相关(r=0.471, P〈0.001)。多元回归分析表明:血浆t-PAIC与LDL-C、Glu、WBC(β系数=0.673、0.305、0.263,P=0.037、0.002、0.006)呈正相关。此外,在预后不良的患者中,t-PAIC水平异常升高(H=82.210, P〈0.001)。结论血浆t-PAIC是冠心病的独立危险因素,该指标升高提示发生冠心病的可能性增加和冠心病患者的预后不良。 Objective The aim of this study was to discuss the effect and clinical value of plasma Tissue Plasminogen Activator-Plasminogen Activator Inhibitor-1 Complex (t-PAIC) in the coronary heart disease (CAD).Methods This is a retrospective study. From January 2017 to March 2018, 203 patients with CAD were recruited from Renmin Hospital of Wuhan University. 130 cases were selected for control group at the same period. Plasma concentrations of t-PAIC, blood RBC, Hb, WBC and other routine biochemical markers were quantified.Results The plasma t-PAIC level in CAD group 12.75(9.0-17.93) ng/ml was significantly higher than that in healthy control group 7.70(6.10-9.41) ng/ml (Z=9.208, P〈0.001). Logistic regression analysis showed that the TG, LPa, t-PAIC were independent risk factors for CAD[OR(95%CI)], [1.762(1.076-2.884); 1.002(1.000-1.003); 1.338 (1.171-1.529)]. The t-PAIC level was positively correlated with the severity of CAD. Compared with control group, the level of t-PAIC was higher in mild group(11.64±0.59)ng/ml and severe group(15.84±0.72)ng/ml, and the plasma t-PAIC level was positively correlated with Gensini score(r=0.471, P〈0.001). Multiple linear regression analysis showed that there was a positive correlation among the plasma t-PAIC and LDL-C, Glu, WBC (β coefficient=0.673, 0.305, 0.263, P=0.037, 0.002, 0.006). In addition, there was abnormal increase of plasma t-PAIC in CAD patients with poor prognosis (H=82.210, P〈0.001).Conclusion Plasma t-PAIC is an independent risk factor of CAD. The significantly increase of plasma t-PAIC might be an important predictor of incidence of CAD and unfavourable prognosis.
作者 郭晓倩 任玮 李艳 Guo Xiaoqian;Ren Wei;Li Yan(Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, Chin)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2018年第6期420-424,共5页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金(81772265,81572069,81501815)
关键词 冠心病 组织型纤溶酶原激活物 纤溶酶原激活物抑制物1 危险因素 Coronary disease Tissue plasminogen activator Plasminogen activator inhibitor 1 Risk factors
  • 相关文献

参考文献7

二级参考文献82

  • 1郑萍,徐恩英.血栓调节蛋白、凝血酶-抗凝血酶复合物和D-二聚体在弥散性血管内凝血诊断中的应用[J].中国基层医药,2006,13(2):189-190. 被引量:6
  • 2王志新,李艳萍.弥漫性血管内凝血患者分子标志物的临床价值[J].医药论坛杂志,2006,27(6):94-95. 被引量:5
  • 3[1]Minno GD. Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction [J]- Ateriosclerosis, 1990, 10: 1-7.
  • 4[2]Acevedo M, Foody JM,Pearce GL, et al. Fibrinogen: associations with cardiovascular events in an outpatient clinic [J]. Am Heart J ,2002,143 (2) :277-282.
  • 5[3]Tanne D. Benderly M ,Goldbourt U ,et al. A prospective study of plasma fibfinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study [ J ]. Am J Med, 2001,111 (6): 457-463.
  • 6[4]Carter AM, Catto AJ, Bamford LM, et al. Gender-specific associations of the fibrinogen Bβ448.polymorphism, fibrinogen levels, and acute cerebrovascular disease[J]. Arterioscler Thromb Vase Biol, 1997,17:589-594.
  • 7[5]Maat MPM, Knijff P, Green FR, et al. Gender-related association between βfibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greeland inuit[J]. Arterioscler Thromb Vasc Biol, 1995.15:856-860.
  • 8[6]Humphries SE, Luong LA, Montgomery HE,et al. Gene-environment interaction in the determination of levels of plasma fibrinogen[ J]. Thromb Haemost,1999,82:818-825.
  • 9[7]Levenson J, Giral P, Razavian M, et al. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors [J]. Arterioscler Thromb Vasc Biol,1995,15:1263-1268.
  • 10[8]Maresca G, Blasio AD, Marchioli R, et al. Measuring plasma fibrinogen to predict stroke and myocardial infarction an update [J]. Arterioscler Thromb Vasc Biol, 1999,19:1368-1377.

共引文献174

同被引文献109

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部